Correlation Between Entero Therapeutics, and Novartis
Can any of the company-specific risk be diversified away by investing in both Entero Therapeutics, and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entero Therapeutics, and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entero Therapeutics, and Novartis AG ADR, you can compare the effects of market volatilities on Entero Therapeutics, and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entero Therapeutics, with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entero Therapeutics, and Novartis.
Diversification Opportunities for Entero Therapeutics, and Novartis
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Entero and Novartis is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Entero Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entero Therapeutics, are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Entero Therapeutics, i.e., Entero Therapeutics, and Novartis go up and down completely randomly.
Pair Corralation between Entero Therapeutics, and Novartis
Given the investment horizon of 90 days Entero Therapeutics, is expected to generate 5.93 times more return on investment than Novartis. However, Entero Therapeutics, is 5.93 times more volatile than Novartis AG ADR. It trades about 0.07 of its potential returns per unit of risk. Novartis AG ADR is currently generating about 0.04 per unit of risk. If you would invest 44.00 in Entero Therapeutics, on November 18, 2024 and sell it today you would earn a total of 7.00 from holding Entero Therapeutics, or generate 15.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Entero Therapeutics, vs. Novartis AG ADR
Performance |
Timeline |
Entero Therapeutics, |
Novartis AG ADR |
Entero Therapeutics, and Novartis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Entero Therapeutics, and Novartis
The main advantage of trading using opposite Entero Therapeutics, and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entero Therapeutics, position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.Entero Therapeutics, vs. Crinetics Pharmaceuticals | Entero Therapeutics, vs. Rhythm Pharmaceuticals | Entero Therapeutics, vs. Kura Oncology | Entero Therapeutics, vs. CytomX Therapeutics |
Novartis vs. AstraZeneca PLC ADR | Novartis vs. GlaxoSmithKline PLC ADR | Novartis vs. Roche Holding Ltd | Novartis vs. Bristol Myers Squibb |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Stocks Directory Find actively traded stocks across global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
CEOs Directory Screen CEOs from public companies around the world |